Drug and Device Manufacturer Communications With Payors, Formulary Committees, and Similar Entities—Questions and Answers; Revised Draft Guidance for Industry
FDA-2016-D-1307-0037Other
Comments
1
Last activity Jul 7, 2026
Deadline
--
Closed Aug 4, 2026
Net supportiSupport minus oppose · campaigns included
0%
0% excluding campaigns
Document
Details
The document's own metadata, straight from the source system.
- Title
- Drug and Device Manufacturer Communications With Payors, Formulary Committees, and Similar Entities—Questions and Answers; Revised Draft Guidance for Industry
- Posted
- Jun 3, 2026
- Comment period
- Jun 3, 2026 – Aug 4, 2026
Analysis
Overview
What the public is saying — stance, who's commenting, and the issues they raise.
Include campaigns
Stance breakdown
0%
Net support
Other1
Aggregates include form-letter campaigns. Excluding them, net support is 0% across organic comments.
Who commented
Breakdown by commenter type.
Individual
1
Comments over time
Weekly arrivals, stacked by stance.
Posted Jun 3, 2026Deadline Aug 4, 2026
Jul 6
Support0Oppose0Other1
Support × commenter type
How each type splits across stance.
Support
Oppose
Other
Individual
0%
0%
100%
Issues raised
The docket's canonical issues. Select one to browse its comments.
Issues are identified as comment analysis progresses — nothing tagged on this document yet.
Comments
Explorer
Every mirrored comment — filter by stance, campaign, or issue.